VNDA Vanda Pharmaceuticals Inc. Stock Quote

VNDA [NASD]

Index	-	P/E	30.54	EPS (ttm)	0.32	Insider Own	3.30%	Shs Outstand	56.10M	Perf Week	-3.90%
Market Cap	541.80M	Forward P/E	56.59	EPS next Y	0.17	Insider Trans	-8.84%	Shs Float	54.48M	Perf Month	-10.84%
Income	18.10M	PEG	0.85	EPS next Q	0.11	Inst Own	-	Short Float	7.69%	Perf Quarter	-26.40%
Sales	266.20M	P/S	2.04	EPS this Y	37.70%	Inst Trans	3.97%	Short Ratio	7.78	Perf Half Y	-44.17%
Book/sh	8.95	P/B	1.07	EPS next Y	-43.33%	ROA	3.10%	Target Price	10.00	Perf Year	-46.14%
Cash/sh	7.73	P/C	1.25	EPS next 5Y	36.10%	ROE	3.60%	52W Range	9.24 - 21.86	Perf YTD	-38.69%
Dividend	-	P/FCF	9.25	EPS past 5Y	27.80%	ROI	6.50%	52W High	-56.00%	Beta	0.58
Dividend %	-	Quick Ratio	5.40	Sales past 5Y	13.00%	Gross Margin	90.50%	52W Low	4.11%	ATR	0.47
Employees	278	Current Ratio	5.40	Sales Q/Q	-4.00%	Oper. Margin	9.10%	RSI (14)	39.89	Volatility	4.13% 5.05%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-174.90%	Profit Margin	6.80%	Rel Volume	0.83	Prev Close	9.74
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 05 AMC	Payout	0.00%	Avg Volume	538.26K	Price	9.62
Recom	3.00	SMA20	-3.19%	SMA50	-11.34%	SMA200	-34.58%	Volume	444,682	Change	-1.23%

Feb-25-22

Downgrade

Jefferies

Buy → Hold

$24 → $12

May-12-21

Initiated

BofA Securities

Buy

$22

Jan-14-21

Downgrade

Citigroup

Buy → Neutral

$14

Oct-29-20

Upgrade

Citigroup

Neutral → Buy

$14

Jun-09-20

Downgrade

Citigroup

Buy → Neutral

$14

Mar-16-20

Downgrade

Oppenheimer

Perform → Underperform

Mar-12-20

Upgrade

Citigroup

Neutral → Buy

$14

Nov-07-19

Downgrade

Citigroup

Buy → Neutral

$19

Aug-01-19

Upgrade

Citigroup

Neutral → Buy

$19

Jul-25-19

Downgrade

Stifel

Buy → Hold

$26 → $17

Dec-11-18

Downgrade

Oppenheimer

Outperform → Perform

Dec-04-18

Upgrade

Cantor Fitzgerald

Neutral → Overweight

Dec-04-18

Reiterated

Jefferies

Buy

$30 → $40

Nov-08-18

Resumed

Jefferies

Buy

Sep-21-18

Resumed

Oppenheimer

Outperform

May-23-18

Initiated

Citigroup

Buy

$26

Jan-19-18

Initiated

Seaport Global Securities

Buy

$20

Sep-14-17

Reiterated

Piper Jaffray

Overweight

$23 → $26

Jun-27-17

Resumed

Piper Jaffray

Overweight

$23

May-26-17

Initiated

H.C. Wainwright

Buy

$18

May-19-22 07:00PM	Vanda Pharmaceuticals Announces Presentations at DDW 2022 PR Newswire
May-05-22 07:15PM	Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:10PM	Vanda Pharmaceuticals Reports First Quarter 2022 Financial Results PR Newswire
May-04-22 04:30PM	Vanda Pharmaceuticals Announces Participation in the BofA Securities 2022 Healthcare Conference PR Newswire
Apr-28-22 05:00PM	Vanda Pharmaceuticals to Announce First Quarter 2022 Financial Results on May 5, 2022 PR Newswire
Apr-27-22 03:03PM	Earnings Preview: Vanda Pharmaceuticals (VNDA) Q1 Earnings Expected to Decline Zacks
Mar-28-22 12:47PM	Vanda Pharmaceuticals (NASDAQ:VNDA) shareholders have endured a 38% loss from investing in the stock three years ago Simply Wall St.
Feb-23-22 04:01PM	Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results PR Newswire
Feb-17-22 06:00PM	Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022 PR Newswire
Feb-09-22 12:25PM	Biotech Stock Roundup: BMY, AMGN, REGN, BIIB's Q4 Earnings & More Zacks
Feb-04-22 12:52PM	A local biotechs latest clinical trial just failed. Heres what that means. American City Business Journals -17.88%
08:34AM	Why Are Vanda Pharma Shares Plunging Today? Benzinga
07:00AM	Vanda Pharmaceuticals Reports Results from the Phase III Study of Tradipitant in Gastroparesis PR Newswire
Jan-26-22 10:48AM	Declining Stock and Decent Financials: Is The Market Wrong About Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)? Simply Wall St.
Jan-24-22 02:48PM	It's been a tough year so far on Wall Street. These D.C.-area companies have suffered the biggest hits. American City Business Journals
Jan-21-22 05:38PM	Denali Advisors Llc Buys Sanmina Corp, Mueller Industries Inc, BlueLinx Holdings Inc, Sells , ... GuruFocus.com
Jan-19-22 09:38AM	Profit Investment Management, LLC Buys Patterson Inc, Vanda Pharmaceuticals Inc, Plantronics ... GuruFocus.com
Jan-18-22 02:41PM	Vanda Pharmaceuticals settles with generic competitor American City Business Journals -5.47%
Jan-02-22 04:04PM	Oil Up, but COVID-19-fuelled Fuel Demand Worries Cap Gains Investing.com
Dec-08-21 11:34AM	Is There An Opportunity With Vanda Pharmaceuticals Inc.'s (NASDAQ:VNDA) 42% Undervaluation? Simply Wall St.
Nov-10-21 06:30PM	Vanda Pharmaceuticals Announces Participation at November 2021 Investor Conferences PR Newswire
Nov-03-21 10:01PM	Vanda Pharmaceuticals Inc (VNDA) Q3 2021 Earnings Call Transcript Motley Fool
06:05PM	Vanda Pharmaceuticals (VNDA) Misses Q3 Earnings and Revenue Estimates Zacks
04:01PM	Vanda Pharmaceuticals Reports Third Quarter 2021 Financial Results PR Newswire
Oct-27-21 05:30PM	Vanda Pharmaceuticals to Announce Third Quarter 2021 Financial Results on November 3, 2021 PR Newswire
Oct-23-21 06:08AM	15 Biotech and Pharmaceutical Stocks to Buy According to Palo Alto Investors Insider Monkey
Oct-20-21 03:03PM	Vanda Pharmaceuticals (VNDA) Earnings Expected to Grow: What to Know Ahead of Q3 Release Zacks
Oct-15-21 12:09PM	Investors in Vanda Pharmaceuticals (NASDAQ:VNDA) have made a decent return of 66% over the past year Simply Wall St.
Oct-14-21 04:30PM	Vanda Pharmaceuticals Announces Participation at Evercore ISI's Catalyst Day PR Newswire
Sep-21-21 12:00PM	Vanda (VNDA) Upgraded to Buy: Here's Why Zacks
Sep-17-21 10:35AM	Notable Vanda Pharmaceuticals Insider Trades $418.64 Thousand In Company Stock Benzinga
Sep-07-21 08:30PM	Vanda Pharmaceuticals Announces Participation at the Citi 16th Annual BioPharma Virtual Conference PR Newswire
Aug-18-21 03:05PM	Should Weakness in Vanda Pharmaceuticals Inc.'s (NASDAQ:VNDA) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? Simply Wall St.
Aug-10-21 06:30PM	Oil Up Over Brighter Fuel Demand Outlook, but COVID-19 Challenges Remain Investing.com
Aug-05-21 10:00AM	Vanda (VNDA) Loses 21.1% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Zacks
Aug-03-21 01:22PM	Ultragenyx (RARE) Q2 Loss Widens Y/Y, Revenues Beat Estimates Zacks
07:00AM	Vanda Pharmaceuticals Closes Enrollment In The ODYSSEY Study Comparing Tradipitant And Placebo In Hospitalized COVID-19 Pneumonia Patients PR Newswire
Jul-30-21 12:10PM	Agios' (AGIO) Q2 Loss Narrows, Pipeline Makes Solid Progress Zacks -8.73%
12:00PM	Vanda (VNDA) Upgraded to Buy: What Does It Mean for the Stock? Zacks
11:23AM	Blueprint Medicines (BPMC) Misses on Q2 Earnings & Revenues Zacks
Jul-29-21 12:32AM	Vanda Pharmaceuticals Inc (VNDA) Q2 2021 Earnings Call Transcript Motley Fool -8.50%
Jul-28-21 08:25PM	Vanda Pharmaceuticals (VNDA) Matches Q2 Earnings Estimates Zacks
04:01PM	Vanda Pharmaceuticals Reports Second Quarter 2021 Financial Results PR Newswire
Jul-26-21 04:07PM	Were Hedge Funds Right About Vanda Pharmaceuticals Inc. (VNDA)? Insider Monkey
Jul-23-21 03:26PM	Notice of Settlement of Derivative Suit GlobeNewswire
Jul-21-21 04:30PM	Vanda Pharmaceuticals to Announce Second Quarter 2021 Financial Results on July 28, 2021 PR Newswire
Jul-01-21 04:54AM	Vanda (VNDA) Moves 5.8% Higher: Will This Strength Last? Zacks
Jun-30-21 07:42AM	Vanda Pharmaceuticals Inc.'s (NASDAQ:VNDA) Intrinsic Value Is Potentially 92% Above Its Share Price Simply Wall St. +5.75%
Jun-21-21 08:45PM	Oil Up, Brent Tops $75 Mark as Signs of Rapidly Tightening Market Emerge Investing.com
Jun-08-21 03:16PM	Top Biotech Stocks for Q3 2021 Investopedia
May-30-21 08:26PM	Oil Up as Fuel Demand Continue to Increase, Investors Focus on OPEC+ Meeting Investing.com
May-12-21 04:30PM	Vanda Pharmaceuticals Announces Participation at Upcoming 2021 Investor Conferences PR Newswire
May-07-21 10:25AM	Did Business Growth Power Vanda Pharmaceuticals' (NASDAQ:VNDA) Share Price Gain of 113%? Simply Wall St.
May-06-21 09:53PM	Oil Up, Gains Fueled by Better-Than-Expected U.S. and Chinese Economic Data Investing.com +5.61%
May-05-21 09:30PM	Vanda Pharmaceuticals Inc (VNDA) Q1 2021 Earnings Call Transcript Motley Fool
06:15PM	Vanda Pharmaceuticals (VNDA) Surpasses Q1 Earnings and Revenue Estimates Zacks
04:01PM	Vanda Pharmaceuticals Reports First Quarter 2021 Financial Results PR Newswire
02:45PM	Vanda Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
May-04-21 07:30AM	NOTICE For Investors In NASDAQ: VNDA Shareholder Notice: Update in Lawsuit Against Vanda Pharmaceuticals Inc. Announced by Shareholders Foundation Newsfile
Apr-29-21 09:01PM	Oil Down But Set for Weekly Gain Over Strengthening Demand in U.S., China Investing.com
Apr-28-21 12:34PM	Vanda Pharmaceuticals (VNDA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Apr-25-21 02:00AM	Lifshitz Law Firm, P.C. Announces Investigations of Jeld-Wen Holding, Inc. (NYSE: JELD), Merit Medical Systems, Inc. (NasdaqGS: MMSI), RCI Hospitality Holdings, Inc. (NasdaqGM: RICK), and Vanda Pharmaceuticals, Inc. (NasdaqGS: VNDA) GlobeNewswire
Apr-20-21 04:30PM	Vanda Pharmaceuticals to Announce First Quarter 2021 Financial Results on May 5, 2021 PR Newswire
Apr-16-21 10:50PM	VANDA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Vanda Pharmaceuticals Inc. - VNDA PR Newswire
02:33PM	Lifshitz Law Firm, P.C. Announces Investigations of Inovio Pharmaceuticals, Inc. (NasdaqGS: INO), Merit Medical Systems, Inc. (NasdaqGS: MMSI), RCI Hospitality Holdings, Inc. (NasdaqGM: RICK), and Vanda Pharmaceuticals, Inc. (NasdaqGS: VNDA) GlobeNewswire
Apr-13-21 08:15AM	Update in Lawsuit for Investors in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Shares Announced by Shareholders Foundation ACCESSWIRE
Apr-06-21 06:40AM	With Sales Expected To Rise, Vanda Pharmaceuticals Stock Could Surge TipRanks
Mar-23-21 07:15AM	NASDAQ: VNDA Investor Notice: Update in Lawsuit against Vanda Pharmaceuticals Inc. announced by Shareholders Foundation GlobeNewswire -6.64%
Mar-18-21 04:26PM	Shuman, Glenn & Stecker Investigates Vanda Pharmaceuticals Inc. Business Wire
09:11AM	Return On Capital Employed Overview: Vanda Pharmaceuticals Benzinga
Mar-17-21 01:56PM	SHAREHOLDER ALERT: Barr Law Group Investigating VNDA, VLDR, RIDE, and ABT; Shareholders are Encouraged to Contact the Firm GlobeNewswire
Mar-12-21 10:50PM	VANDA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Vanda Pharmaceuticals Inc. - VNDA Business Wire
Mar-11-21 01:52PM	Shareholder Alert: Robbins LLP Announces that Vanda Pharmaceuticals Inc. (VNDA) Class Action Survives Motion to Dismiss Business Wire
Feb-23-21 02:49PM	Pacira Pharmaceuticals Getting Closer To Key Technical Measure Investor's Business Daily
Feb-14-21 01:32PM	15 Best Small-Cap Healthcare Stocks to Buy Insider Monkey
Feb-12-21 12:54AM	Vanda Pharmaceuticals Inc. Just Missed Earnings - But Analysts Have Updated Their Models Simply Wall St.
Feb-11-21 10:28AM	Return On Capital Employed Overview: Vanda Pharmaceuticals Benzinga +21.16%
Feb-10-21 08:30PM	Vanda Pharmaceuticals Inc (VNDA) Q4 2020 Earnings Call Transcript Motley Fool
04:28PM	Recap: Vanda Pharmaceuticals Q4 Earnings Benzinga
04:01PM	Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results PR Newswire
07:34AM	The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs Benzinga
Feb-02-21 04:30PM	Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results on February 10, 2021 PR Newswire
Dec-19-20 06:11PM	Is VNDA A Good Stock To Buy Now According To Hedge Funds? Insider Monkey
Dec-02-20 03:02PM	Here's Why Vanda Pharmaceuticals Jumped Higher Today Motley Fool +9.32%
07:35AM	The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod Benzinga
Dec-01-20 06:00PM	FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome PR Newswire
04:47AM	Vanda Pharmaceuticals Inc.'s (NASDAQ:VNDA) Stock Is Going Strong: Have Financials A Role To Play? Simply Wall St.
Nov-17-20 12:43PM	Bristol Myers' (BMY) CAR T-Cell Therapy BLA Review Delayed Zacks
Oct-29-20 09:31AM	Benzinga's Top Upgrades, Downgrades For October 29, 2020 Benzinga +8.97%
Oct-28-20 05:55PM	Vanda Pharmaceuticals (VNDA) Q3 Earnings Surpass Estimates Zacks
04:01PM	Vanda Pharmaceuticals Reports Third Quarter 2020 Financial Results PR Newswire
02:30PM	Vanda Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Oct-26-20 04:01PM	Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VSJ-110 for Allergic Conjunctivitis PR Newswire
Oct-21-20 04:45PM	Vanda Pharmaceuticals to Announce Third Quarter 2020 Financial Results on October 28, 2020 PR Newswire
Oct-13-20 01:14PM	Vanda Pharmaceuticals Inc. (VNDA): Hedge Funds Taking Some Chips Off The Table Insider Monkey
Oct-02-20 01:44PM	How Does Vanda Pharmaceuticals' (NASDAQ:VNDA) CEO Pay Compare With Company Performance? Simply Wall St.
Aug-31-20 06:30PM	Vanda Pharmaceuticals Provides Update on Tradipitant Development Program PR Newswire
Aug-18-20 10:24AM	Would Shareholders Who Purchased Vanda Pharmaceuticals'(NASDAQ:VNDA) Stock Three Years Be Happy With The Share price Today? Simply Wall St. -8.20%
07:00AM	Vanda Pharmaceuticals' Interim Analysis from ODYSSEY Study Shows Tradipitant may Accelerate Clinical Improvement in Patients with COVID-19 Pneumonia PR Newswire
Aug-06-20 08:21PM	Oil Down But OPEC+ Member Cuts Cap Losses Investing.com

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under development include HETLIOZ (tasimelteon) for the treatment of jet lag disorder, smith-magenis syndrome, pediatric Non-24, autism spectrum, and delayed sleep phase disorder; Fanapt (iloperidone) for the treatment of bipolar disorder and a long acting injectable formulation program for the treatment of schizophrenia; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist, for the treatment of atopic dermatitis, gastroparesis, and motion sickness. The company's products under development also comprise VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist for the treatment of psychiatric disorders; a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors for the treatment of dry eye and ocular inflammation, as well as BPO-27 for the treatment of secretory diarrhea disorders, including cholera; and VHX-896, the active metabolite of iloperidone. It markets its products in the United States, Europe, and Israel. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Birznieks Gunther	SVP, Business Development	Mar 02	Sale	11.27	11,517	129,792	188,807	Mar 02 09:26 PM
Polymeropoulos Mihael Hristos	President and CEO	Mar 02	Sale	11.15	29,588	329,945	1,352,766	Mar 02 09:27 PM
Wijkstrom Joakim	SVP, Chief Marketing Officer	Mar 02	Sale	11.19	6,974	78,060	100,278	Mar 02 09:28 PM
Williams Timothy	SVP & General Counsel	Mar 02	Sale	11.09	12,060	133,779	103,851	Mar 02 09:29 PM
Moran Kevin Patrick	SVP, CFO & Treasurer	Mar 02	Sale	11.28	8,832	99,650	119,691	Mar 02 09:27 PM
Moran Kevin Patrick	SVP, CFO & Treasurer	Mar 01	Sale	11.19	3,473	38,863	128,523	Mar 02 09:27 PM
Polymeropoulos Mihael Hristos	President and CEO	Mar 01	Sale	11.19	7,508	84,015	1,382,354	Mar 02 09:27 PM
Birznieks Gunther	SVP, Business Development	Mar 01	Sale	11.19	4,084	45,700	200,324	Mar 02 09:26 PM
Polymeropoulos Mihael Hristos	President and CEO	Dec 01	Option Exercise	4.88	71,676	349,779	1,321,062	Dec 02 04:31 PM
Polymeropoulos Mihael Hristos	President and CEO	Dec 01	Sale	16.00	46,200	739,348	1,274,862	Dec 02 04:31 PM
Polymeropoulos Mihael Hristos	President and CEO	Nov 30	Option Exercise	4.88	78,324	382,221	1,299,386	Dec 02 04:31 PM
Polymeropoulos Mihael Hristos	President and CEO	Nov 30	Sale	16.49	50,000	824,275	1,249,386	Dec 02 04:31 PM
Jones Aranthan II	Chief Corp. Affairs Officer	Sep 15	Option Exercise	11.66	12,119	141,250	98,804	Sep 17 08:52 AM
Jones Aranthan II	Chief Corp. Affairs Officer	Sep 15	Sale	16.49	16,824	277,394	81,980	Sep 17 08:52 AM
Mitchell Stephen Ray	Director	Sep 09	Option Exercise	12.03	19,109	229,936	28,324	Sep 13 04:40 PM
Mitchell Stephen Ray	Director	Sep 09	Sale	16.74	19,109	319,976	9,215	Sep 13 04:40 PM
Wijkstrom Joakim	SVP, Chief Marketing Officer	Aug 20	Sale	15.39	3,650	56,190	74,552	Aug 23 04:36 PM
Williams Timothy	SVP & General Counsel	Aug 16	Sale	16.15	3,715	59,989	83,211	Aug 17 04:31 PM
Moran Kevin Patrick	SVP, CFO & Treasurer	Jul 28	Sale	19.24	2,130	40,973	99,296	Jul 30 09:15 AM
Jones Aranthan II	Chief Corp. Affairs Officer	Jul 26	Sale	19.69	7,250	142,776	86,685	Jul 27 04:37 PM
Chrousos Phaedra	Director	Jun 14	Sale	19.34	2,075	40,132	12,925	Jun 15 04:42 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience